{"id":14477,"date":"2024-02-23T17:43:16","date_gmt":"2024-02-23T17:43:16","guid":{"rendered":"http:\/\/TheNextWeb=1404209"},"modified":"2024-02-23T17:43:16","modified_gmt":"2024-02-23T17:43:16","slug":"this-startup-is-bioengineering-tissue-into-human-vein-implants","status":"publish","type":"post","link":"https:\/\/www.londonchiropracter.com\/?p=14477","title":{"rendered":"This startup is bioengineering tissue into human vein implants"},"content":{"rendered":"\n

Norwegian startup ClexBio is bioengineering human veins to implant inside a patient\u2019s body.<\/p>\n

Together with CSEM, a Swiss R&D centre, the company has built a prototype bioreactor to grow the veins.<\/p>\n

Pre-clinical tests in animal models are already underway. Based on the early results, the team is confident that the implants don\u2019t trigger an immune response in patients. Instead, they turn into functional tissue that integrates with the body.<\/p>\n

If further tests prove successful, the implants could treat severe chronic venous insufficiency, a painful condition caused when veins have problems moving blood to the heart.<\/p>\n

\n
<\/p>\n

TNW Conference 2024 – Group ticket offer<\/p>\n

Save up to 40% with our Group offer and join Europe’s leading tech festival in June!<\/p>\n

<\/a><\/div>\n<\/div>\n

But veins are just the start of the company\u2019s ambitions. ClexBio<\/a> envisions bioengineering producing various medical treatments.<\/p>\n

\u201cIn the future, we believe tissue therapeutic solutions will provide a cure for many of the chronic conditions that are debilitating for our society today,\u201d Armend H\u00e5ti, the startup\u2019s CEO and co-founder, told TNW.<\/p>\n

Bioengineering body parts<\/h2>\n
\"A
<\/i><\/a>The new tech aims to scale bioengineering. Credit: ClexBio<\/figcaption>